Related Experiment Videos
Are Phe-Met-Arg-Phe-NH2 immunoreactive peptides endacoids modulating opiate antinociception?
Progress in Clinical and Biological Research
|January 1, 1985
Summary
Phe-Met-Arg-Phe-NH2 (FMRF-NH2) and its related immunoreactivity modulate opioid pain relief. These findings suggest FMRF-NH2-like immunoreactivity may act as an endogenous naloxone, influencing pain perception.
Area of Science:
- Neuroscience
- Pharmacology
- Peptide Research
Background:
- Phe-Met-Arg-Phe-NH2 (FMRF-NH2) is a peptide initially isolated from mollusks.
- FMRF-NH2-like immunoreactivity (FMRF-NH2-IR) has been identified in mammalian central nervous systems (CNS).
- Structural similarities exist between FMRF-NH2 and met5-enkephalin-arg6-phe7 (YGGFMRF), suggesting potential interactions.
Purpose of the Study:
- To explore the interaction between FMRF-NH2 and opioid peptides.
- To characterize the biological profile of endogenous FMRF-NH2-IR in modulating pain.
- To investigate the role of FMRF-NH2-IR in opioid analgesia.
Main Methods:
- Intrathecal injections of FMRF-NH2 and partially purified FMRF-NH2-IR were administered.
- The effects on antinociception of YGGFMRF and morphine were assessed.
- The influence of proglumide (a CCK antagonist) and FMRF-NH2 antibodies on analgesia was evaluated.
Main Results:
- Intrathecal FMRF-NH2 decreased the antinociceptive effects of YGGFMRF and morphine.
- Partially purified bovine FMRF-NH2-IR also reduced YGGFMRF antinociception.
- Both proglumide and FMRF-NH2 antibodies potentiated morphine analgesia, suggesting FMRF-NH2-IR modulates opioid effects.
Conclusions:
- Endogenous FMRF-NH2-IR appears to play a role in modulating opioid antinociception.
- FMRF-NH2-IR might function as an endogenous naloxone, influencing the effectiveness of opioid pain relief.
- These findings open new avenues for understanding pain modulation pathways.